Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking. What You Should Know: – Advancements in accelerating early Alzheimer’s disease…
Dive Brief: Quest Diagnostics is planning to offer laboratory testing based on Fujirebio Diagnostics’ recently Food and Drug Administration-authorized Alzheimer’s…